Predicting Future Price Moves In Minerva Surgical Inc. (UTRS)


Minerva Surgical Inc. (NASDAQ:UTRS) does about 1.83M shares in volume on a normal day but saw 417069 shares change hands in Friday trading. The company now has a market cap of 11.09M USD. Its current market price is $0.43, marking an increase of 2.58% compared to the previous close of $0.42. The 52 week high reached by this stock is $6.04 whilst the lowest price level in 52 weeks is $0.15. The script in recent trading has seen the stock touch a high of $0.4499 and a low of $0.388.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.


Minerva Surgical Inc. (UTRS) has a 20-day trading average at $0.4109 and the current price is -92.88% off the 52-week high compared with 186.95% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.2895 and its 200-day simple moving average is $1.2395. If we look at the stock’s price movements over the week, volatility stands at 23.11%, which increases to 29.01% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 56.42 to suggest the stock is neutral.

1 analysts observing the Minerva Surgical Inc. (UTRS) stock have set the 12-month price targets for the company’s shares at between $5.00 and $5.00. The consensus objective for the share price is $5.00, suggesting that the stock has a potential upside of 91.4% over the period. The median price target is 91.4% away from the current levels at $5.00.

FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 1 analysts have rated it as a sell, while 0 advise that it is a overweight. 0 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Sell and Wall Street’s advice is for investors to Hold the stock.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on November 16, 2021 when UBS initiated the stock to “Buy” and issued a price target of $15. Piper Sandler initiated its price target at $17.

The current price level is 7.54%, 51.14%, and -65.62% away from its SMA20, SMA50, and SMA200 respectively, with the UTRS price moving below the 50-day SMA on February 17. Minerva Surgical Inc. (UTRS) stock is down -9.85% over the week and 98.20% over the past month. Its price is 92.52% year-to-date and -92.17% over the past year.

The stock last released its quarterly earnings report for quarter ended 9/29/2022, with the company’s earnings per share (EPS) of -$0.4 below consensus estimates by -$0.12. The company’s next earnings report is expected on 05/10/2023, with forecasts estimating quarterly EPS at -$0.28 and -$1.26 for whole year. UTRS’s earnings per share are forecast to grow by 76.80% this year and -9.50% over next year. Expected sales for next quarter are $12.7 million, which analysts say will come at $51 million for the current fiscal year and next year at $55 million. In addition, estimates put the company’s current quarterly revenue at an average of $15 million.

Its 12-month price target is $5.00. To reach the target analysts have set, the stock logically needs to grow 91.4 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $5.00, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $5.00.

Outstanding shares total 28.61M with insiders holding 6.23% of the shares and institutional holders owning 70.12% of the company’s common stock. The company has a return on investment of -56.90% and return on equity of -52.00%. Price to book ratio is 0.57 and price to sales ratio is 0.22.

iShares Tr – Micro Cap ETF isn’t the only investment manager who changed stakes and is followed by Bridgeway Ultra Small Company Mar, which sold off 75000.0 shares to end up with 127,200 shares worth $48463.0.


Please enter your comment!
Please enter your name here